These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8549245)
61. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results. Yonemoto LT; Slater JD; Friedrichsen EJ; Loredo LN; Ing J; Archambeau JO; Teichman S; Moyers MF; Blacharski PA; Slater JM Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):867-71. PubMed ID: 8960515 [TBL] [Abstract][Full Text] [Related]
62. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group. Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774 [TBL] [Abstract][Full Text] [Related]
63. Treatment of foveal pigment epithelial detachments with contiguous extrafoveal choroidal neovascular membranes. Maguire JI; Benson WE; Brown GC Am J Ophthalmol; 1990 May; 109(5):523-9. PubMed ID: 1692183 [TBL] [Abstract][Full Text] [Related]
64. Visual results after submacular surgery for neovascularization in age-related macular degeneration. Roth DB; Downie AA; Charles ST Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179 [TBL] [Abstract][Full Text] [Related]
65. Randomized trial of radiation for age-related macular degeneration. Char DH; Irvine AI; Posner MD; Quivey J; Phillips TL; Kroll S Am J Ophthalmol; 1999 May; 127(5):574-8. PubMed ID: 10334351 [TBL] [Abstract][Full Text] [Related]
66. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study. Thoelen A; Menozzi M; Huber C; Messmer E Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047 [TBL] [Abstract][Full Text] [Related]
67. Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study. Lewis H; Kaiser PK; Lewis S; Estafanous M Am J Ophthalmol; 1999 Aug; 128(2):135-46. PubMed ID: 10458168 [TBL] [Abstract][Full Text] [Related]
68. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Gass JD Am J Ophthalmol; 1994 Sep; 118(3):285-98. PubMed ID: 7521987 [TBL] [Abstract][Full Text] [Related]
69. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389 [TBL] [Abstract][Full Text] [Related]
70. Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration. Marcus DM; Sheils WC; Young JO; McIntosh SB; Johnson MH; Alexander J; Samy CN Br J Ophthalmol; 2004 Jan; 88(1):114-9. PubMed ID: 14693787 [TBL] [Abstract][Full Text] [Related]
72. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Fujii GY; de Juan E; Pieramici DJ; Humayun MS; Phillips S; Reynolds SM; Melia M; Schachat AP Am J Ophthalmol; 2002 Jul; 134(1):69-74. PubMed ID: 12095810 [TBL] [Abstract][Full Text] [Related]
73. Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration. Gabel-Pfisterer A; Laue J; Heimann H; Jandeck C; Kellner U; Bornfeld N; Foerster MH Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):350-4. PubMed ID: 14714187 [TBL] [Abstract][Full Text] [Related]
74. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Bressler NM; Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980 [TBL] [Abstract][Full Text] [Related]
75. Foveal sparing photocoagulation for exudative age-related macular degeneration. Orth DH; Rosculet JP; De Bustros S Retina; 1994; 14(2):153-9. PubMed ID: 7518606 [TBL] [Abstract][Full Text] [Related]
76. Surgical management of subfoveal choroidal neovascularization. Thomas MA; Grand MG; Williams DF; Lee CM; Pesin SR; Lowe MA Ophthalmology; 1992 Jun; 99(6):952-68; discussion 975-6. PubMed ID: 1378583 [TBL] [Abstract][Full Text] [Related]
77. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Schmidt-Erfurth U; Miller J; Sickenberg M; Bunse A; Laqua H; Gragoudas E; Zografos L; Birngruber R; van den Bergh H; Strong A; Manjuris U; Fsadni M; Lane AM; Piguet B; Bressler NM Graefes Arch Clin Exp Ophthalmol; 1998 May; 236(5):365-74. PubMed ID: 9602321 [TBL] [Abstract][Full Text] [Related]
78. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395 [TBL] [Abstract][Full Text] [Related]
79. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization. Thomas MA; Ibanez HE Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842 [TBL] [Abstract][Full Text] [Related]